Propiedad y actividad de insiders de Canopy Growth Corporation (CGC): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $0.92 |
| Capitalización | $387M |
| Bolsa | NASDAQ |
| País | CA |
Operaciones Recientes de Insiders
| Fecha | Insider | Tipo | Acciones | Valor |
|---|---|---|---|---|
| 2026-08-24 | Gedeon Christelle | S-Sale | 13,344 | $20K |
| 2026-08-24 | Stewart Thomas Carlton | S-Sale | 2,231 | $3K |
| 2026-06-26 | BAYERN JOSEPH | S-Sale | 3,197 | $3K |
| 2026-06-26 | Yanofsky Theresa | S-Sale | 15,054 | $14K |
| 2026-06-26 | ATKINS M SHAN | S-Sale | 3,197 | $3K |
| 2026-06-26 | Lazzarato David Angelo | S-Sale | 22,674 | $21K |
| 2026-06-17 | ATKINS M SHAN | A-Award | 108,324 | |
| 2026-06-17 | Lazzarato David Angelo | A-Award | 162,485 | |
| 2026-06-17 | BAYERN JOSEPH | A-Award | 108,324 | |
| 2026-06-17 | Yanofsky Theresa | A-Award | 108,324 |
Balance (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $101.8M | $322.6M | $2.48B | $915.6M | $1.15B | $776.0M | $667.7M | $170.3M | $113.8M | $364.7M |
| Inversiones a Corto | 0 | 0 | $2.06B | $488.2M | $1.16B | $595.7M | $105.5M | $33.2M | $17.7M | $5.1M |
| Cuentas por Cobrar | $5.8M | $21.4M | $107.0M | $63.3M | $67.1M | $86.6M | $68.5M | $51.8M | $52.8M | $36.3M |
| Inventario | $60.7M | $118.0M | $190.1M | $274.8M | $369.5M | $204.5M | $83.2M | $77.3M | $96.4M | $154.1M |
| Activos Corrientes | $178.8M | $481.8M | $4.92B | $1.80B | $2.84B | $1.73B | $1.08B | $371.2M | $294.6M | $529.5M |
| Inmovilizado Material | $96.3M | $303.7M | $1.10B | $1.07B | $1.07B | $942.8M | $471.3M | $320.1M | $293.5M | $441.4M |
| Fondo de Comercio | $241.4M | $314.9M | $1.54B | $1.37B | $1.89B | $1.87B | $85.6M | $43.2M | $46.0M | $77.7M |
| Activos Intangibles | $162.3M | $101.5M | $519.6M | $334.7M | $308.2M | $252.7M | $160.8M | $104.1M | $87.2M | $128.9M |
| Activos Totales | $677.6M | $1.44B | $8.73B | $4.82B | $6.82B | $5.61B | $2.44B | $1.30B | $917.7M | $1.12B |
| Cuentas por Pagar | $5.7M | $46.2M | $188.9M | $86.7M | $67.3M | $64.3M | $31.8M | $28.7M | $26.1M | $34.8M |
| Deuda a Corto | $1.7M | $1.6M | $103.7M | $39.9M | $9.8M | $9.3M | $556.9M | $103.9M | $4.3M | $16.2M |
| Pasivos Corrientes | $17.7M | $92.0M | $411.7M | $295.5M | $284.3M | $213.2M | $803.8M | $234.7M | $94.4M | $158.4M |
| Deuda a Largo | $8.6M | $6.9M | $842.3M | $315.5M | $1.57B | $1.49B | $750.0M | $493.3M | $299.8M | $217.1M |
| Pasivos Totales | $62.9M | $193.6M | $1.49B | $1.18B | $3.20B | $1.98B | $1.68B | $799.8M | $430.5M | $421.1M |
| Reservas | -$21.3M | -$91.6M | -$835.1M | -$3.04B | -$6.07B | -$6.38B | -$9.67B | -$10.33B | -$10.93B | -$11.14B |
| Patrimonio Neto | $639.8M | $1.16B | $6.78B | $3.43B | $3.48B | $3.58B | $758.4M | $500.4M | $487.2M | $697.6M |
| Deuda Total | $10.3M | $8.4M | $946.0M | $439.7M | $1.72B | $1.64B | $1.41B | $668.0M | $348.4M | $278.7M |
| Deuda Neta | -$91.5M | -$314.1M | -$3.60B | -$964.1M | -$598.3M | $268.5M | $640.5M | $464.5M | $216.9M | -$92.0M |
| Capital Circulante | $161.1M | $389.7M | $4.51B | $1.51B | $2.55B | $1.51B | $273.4M | $136.5M | $200.2M | $371.0M |
Salud financiera
| Deuda / Patrimonio | 0.40 |
| Ratio corriente | 3.04 |
Rentabilidad
| Rentabilidad sobre capital | -29.85% |
| Rentabilidad sobre capital invertido | -15.31% |
| Rentabilidad sobre activos | -21.43% |
| Margen bruto | 22.87% |
| Margen operativo | -46.89% |
| Margen neto | -73.95% |
Empresas relacionadas: ACB · ACRS · BIOA · CABA · DH · IRWD · LFCR
Explorar sector: Healthcare · Drug Manufacturers - Specialty & Generic
Más secciones de CGC: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones